|1||Active, not recruiting||
Trial on Refinement of Early Stage Lung Cancer Adjuvant Therapy
A Window of Opportunity Trial of Afatinib In Early Stage Non-Small Cell Lung Cancer (NSCLC)
Vinorelbine Plus Cisplatin or No Further Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Surgically Removed
† Study has passed its completion date and status has not been verified in more than two years.